LTB4 can directly stimulate human osteoclast formation from PBMC independent of RANKL

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 33, Issue 4, 2005, Pages 391-403

  Jiang, Jun ^a   Lv, Hou Shan ^a   Lin, Jian Hao ^a   Jiang, Dong Fang ^a   Chen, Zhan Kun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Bone resorption; Leukotriene B4; Osteoclast; PBMC; TRAP staining

Indexed keywords

BLOOD; CELLS; DISEASES; SORPTION;

BONE RESORPTION; LEUKOTRIENE B4; OSTEOCLAST; PBMC; TRAP STAINING;

METABOLITES;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; LEUKOTRIENE B4; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; OSTEOCLAST; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY MECHANISM;

BONE RESORPTION; CARRIER PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; HUMANS; LEUKOTRIENE B4; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MONOCYTES; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 27844593197     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190500289784     Document Type: Article

References (29)

1. Suda, T., Takahashi, N., Martin, T.J. (1992). Modulation of osteoclast differentiation. Endocr. Rev. 13(1): 66-80.
2. Suda, T., Udagawa, N., Takahashi, N. (1996). Osteoclast generation, in Principles of Bone Biology, 2nd ed., J.P. Bilizikian, L.G. Raisz, G.A. Rodan, Eds., Academic Press: San Diego, CA, pp. 87-102.
3. Athanasou, N.A. (1996). Cellular biology of bone-resorbing cells. J Bone Joint Surg Am. 78(7): 1096-1122.
4. Fujikawa, Y., Quinn, J.M.W., Sabokbar, A., McGee, J.O.D., Athanasou, N.A. (1996). The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137(9): 4058-4060.
5. Khosla, S. (2001). Minireview: the OPG/RANKL/RANK system. Endocrinology 142(12): 5050-5055.
6. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliot, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., Boyle, W.J. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2): 165-176.
7. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamuguchi, K., Kuiyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K. (1998). Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139(3): 1329-1337.
8. Gravallese, E.M., Manning, C., Tsay, A., Naito, A., Pan, C., Amento, E., Goldring, S.R. (2000). Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis & Rheumatism 43(2): 250-258.
9. Hofbauer, L.C., Khosla, D., Dunston, C.R., Lacey, D.L., Boyle, W.J., Riggs, B.L. (2000). The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Mineral Res. 15(1): 2-12.
10. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashinio, K., Martin, T.J., Suda, T. (2000). Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of ODF/RANKL-RANK interaction. J Exp Med. 191(2): 275-286.
11. Fuller, K., Murphy, C., Kirstein, B., Fox, S.W., Chambers, T.J. (2002). TNF-α potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143(3): 1108-118.
12. Jimi, E., Nakamura, I., Duong, L.T., Ikebe, T., Takahashi, N., Rodan, G.A., Suda, T. (1999). Interleukin-1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblast/stromal cells. Exp Cell Res. 247(1): 84-93.
13. Garcia, C., Boyce, B.F., Gilles, J., Dallas, M., Qiao, M., Mundy, G.R., Bonewald L.F. (1996). Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res. 11(11): 1619-1627.
14. Flynn, M.A., Qiao, M., Garcia, C., Dallas, M., Bonewald, L.F. (1999). Avian osteoclast cells are stimulated to resorb calcified matrices by and process receptors for leukotriene B4. Calcif Tissue Int. 64(2): 154-159.
15. Mikin, C. (1982). Bone acid phosphates: Tartrate-resistant acid phosphates as a marker of osteoclast function. Calcif Tissue Int. 34(3): 285-290.
16. Crooks, S.W., Stockley, R.A. Molecules in focus: Leukotriene B4. (1998). Int J Biochem Cell Biol. 30(2): 173-178.
17. Penrose, J.F., Austen, K.F. (1999). The biochemical, molecular, and genomic aspects of leukotriene C4 synthase. Proc Assoc Am Physicians 111(6): 537-546.
18. Los, M., Schenk, H., Hexel, K., Baeuerle, P.A., Droge, W., Schulze-Osthoff, K. (1995). Il-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipooxygenase. EMBO J 14(15): 3731-3740.
19. Gok, S., Ulker, S., Huseyinov, A., Hatip, F.B., Cinar, M.G., Evinc, A. (2000). Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritis rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase. Pharmacology 60(1): 41-46.
20. Ahmadzadeh, N., Shingu, M., Nobunaga, M., Tawara, T. (1991). Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids. Inflammation 15(6): 497-503.
21. Roodman, G.D. (1999). Cell biology of the osteoclast. Exp Hematol. 27(8): 1229-1241.
22. Quinn, J.M., Elliot, J., Gillespie, M.T., Martin, T.J. (1998). A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and osteoclast formation. Endocrinology 139(10): 4424-4427.
23. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Suda, T. (1990). Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U.S.A. 87(18): 7260-7264.
24. Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., Athanasou, N.A. (2003). Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32(1): 1-7.
25. Quinn, J.M.W., Neale, S., Fujikawa, Y., McGee, J.O.D., Athanasou, N.A. (1998). Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int. 62(6): 527-531.
26. Ibbotson, K.J., Roodman, G.D., McManus, L.M., Mundy, G.R. (1984). Identification and characterization of osteoclast-like cells and their progenitors in culture of feline marrow mononuclear cells. J Cell Biol. 99(2): 474.
27. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., Shimizu, T. (1997). A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387(6633): 620-624.
28. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., Shimizu, T. (2000). A second leukotriene B4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med. 192(3): 421-432.
29. Yokomizo, T., Izumi, T., Shimizu, T. (2001). Co-expression of two LTB4 receptors in human mononuclear cells. Life Sci. 68(19-20): 2207-2212.